 Venrock logo | |
| Type | Limited liability company |
|---|---|
| Industry | Venture Capital |
| Founded | 1969 |
| Founder | Laurance Rockefeller |
| Headquarters | Palo Alto, California, United States |
| Products | Investments |
| Website | venrock |
Venrock (portmanteau of Venture and Rockefeller) is a venture capital firm formed in 1969 to build upon the successful investing activities of the Rockefeller family that began in the late 1930s. It has offices in Palo Alto, California, New York City, and Boston, Massachusetts.
Venture capitalist Laurance S. Rockefeller (1910–2004) was the fourth of the six children of John D. Rockefeller Jr. In January 1946 he formed Rockefeller Brothers, Inc., one of the first postwar venture-capital operations, starting with a capitalization of $1.5 million. There were eight partners in all, the five brothers and their sister, Abby, and two non family members Harper Woodward and MIT scientist, Ted Walkowicz. In 1969, the firm became known as Venrock. [1] Laurance S. Rockefeller became an investor in enterprises based on science and technology. His investment interests included the fields of aviation, aerospace, electronics, high temperature physics, composite materials, optics, lasers, data processing, thermionics, and nuclear power.[ citation needed ]
Venrock closed its seventh fund in July 2014 with 8 partners and its eighth fund in January 2017 with 15 partners, each fund totalling $450 million. [2] [3]
Venrock invested more than $2.5 billion in more than 440 companies, resulting in 125 initial public offerings.[ citation needed ] Venrock focuses its investments on early-stage and start-up companies in information technology, healthcare and emerging technologies. These include: Intel, Apple, AppNexus, Astranis, StrataCom, Check Point Software, Dapper Labs, DoubleClick, 3Com Corporation, Mosaic, PGP, Itek, Digex, Interos, [4] Shape Security, Phoenix, Second Rotation (gazelle), RedSeal and CTERA Networks, Juno Therapeutics. It also has a significant venture in the nascent nanotechnology field, with early funding of Nanosys and the nanotech division of Du Pont. [5] Others include BioTime. [6] [7]
In the healthcare sector with partners such as Bryan Roberts, Venrock has invested in athenahealth, Grand Rounds, HealthSouth Corporation, MedPartners, Inc., Castlight Health, Caliper Technologies Corporation, Centocor, Geron, [8] senolytic startup UNITY Biotechnology, [9] Genetics Institute, Idec Pharmaceuticals Corporation, Illumina, Millennium Pharmaceuticals, Sirna Therapeutics, and Sugen.[ citation needed ]
Venture capital is a form of private equity financing that is provided by venture capital firms or funds to startups, early-stage, and emerging companies that have been deemed to have high growth potential or which have demonstrated high growth. Venture capital firms or funds invest in these early-stage companies in exchange for equity, or an ownership stake. Venture capitalists take on the risk of financing risky start-ups in the hopes that some of the companies they support will become successful. Because startups face high uncertainty, VC investments have high rates of failure. The start-ups are usually based on an innovative technology or business model and they are usually from high technology industries, such as information technology (IT), clean technology or biotechnology.
Kleiner Perkins, formerly Kleiner Perkins Caufield & Byers (KPCB), is an American venture capital firm which specializes in investing in incubation, early stage and growth companies. Since its founding in 1972, the firm has backed entrepreneurs in over 900 ventures, including America Online, Amazon.com, Tandem Computers, Compaq, Electronic Arts, JD.com, Square, Genentech, Google, Netscape, Sun Microsystems, Nest, Palo Alto Networks, Synack, Snap, AppDynamics, and Twitter. By 2019 it had raised around $9 billion in 19 venture capital funds and four growth funds.
Draper Fisher Jurvetson (DFJ) is an American venture capital firm focused on investments in enterprise, consumer and disruptive technologies. In January 2019, DFJ Venture, the early-stage team, spun out and formed Threshold Ventures. DFJ Growth continues to be managed by co-founder John Fisher and the existing DFJ Growth partner team.
Sequoia Capital is an American venture capital firm headquartered in Menlo Park, California which specializes in seed stage, early stage, and growth stage investments in private companies across technology sectors. As of 2022, the firm had approximately US$85 billion in assets under management.
SoftBank Capital is a venture capital group in the United States, focusing on technology and telecom early stage businesses. It was founded by SoftBank. Since 2015 it does not actively make investments, but it continues to oversee its prior portfolio.
Index Ventures is a European venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security. Since its founding in 1996, the firm has invested in a number of companies and raised approximately $5.6 billion. Index Venture partners appear frequently on Forbes’ Midas List of the top tech investors in Europe and Israel.
Insight Partners is a global venture capital and private equity firm that invests in high-growth technology, software, and Internet businesses. The company is headquartered in New York City, with offices in London, Tel Aviv, and Palo Alto.
The early history of private equity relates to one of the major periods in the history of private equity and venture capital. Within the broader private equity industry, two distinct sub-industries, leveraged buyouts and venture capital experienced growth along parallel although interrelated tracks.
Advanced Technology Ventures (ATV) is an American venture capital firm with more than $1.8 billion in capital under management. The firm was founded in 1979 and invests in IT, healthcare, and cleantech companies. ATV is based in Menlo Park, California with offices in Waltham, Massachusetts.
Corporate venture capital (CVC) is the investment of corporate funds directly in external startup companies. CVC is defined by the Business Dictionary as the "practice where a large firm takes an equity stake in a small but innovative or specialist firm, to which it may also provide management and marketing expertise; the objective is to gain a specific competitive advantage." Examples of CVCs include GV and Intel Capital.
Terry McGuire is a co-founder and general partner of Polaris Partners based in the Boston office. McGuire focuses on life sciences investments.
New Enterprise Associates (NEA) is an American-based venture capital firm. NEA focuses investment stages ranging from seed stage through growth stage across an array of industry sectors. With ~$25 billion in committed capital, NEA is one of the world's largest venture capital firms.
Atlas Venture is an early-stage venture capital firm that creates and invests in biotechnology startup companies in the U.S. Atlas is headquartered in Cambridge, Massachusetts, where the majority of its investments are located. Atlas raised its thirteenth fund totaling $450 million in March 2022, after raising its Opportunity Fund II totaling $300 million in September 2021.
Foresite Capital is an American venture capital and growth equity firm headquartered in San Francisco. As of March 2021, the company had raised four funds: Foresite Capital Fund I, II, III, IV and V.
Dropel Fabrics is an American technology company that develops, manufactures, and licenses sustainable treatments for natural fabrics to make spill proof and stain proof threads. The company is known for creating the world's first water and stain repellent naturals fabrics that maintain their softness and breathability.
William H.Rastetter, a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics, and of Daré Bioscience, Inc. in San Diego, California. He is a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a period as the company's interim CEO (2017) and chair (2017-2018). Rastetter is also a director of Regulus Therapeutics and Entos, Inc.. He was a partner in the venture firm Venrock (2006-2013), and a trustee at Caltech (2015-2018). He has served as a director (1998-2016) and as chair of Illumina (2005-2016). He advised SVB Leerink (2014-2019) and currently advises Illumina Ventures.
OrbiMed is an American investment firm based in New York City, United States. It is focused on making public and private investments in the Healthcare and Biotechnology industries. OrbiMed is considered to be one of the largest dedicated healthcare investment firms in the world.
Canaan Partners (Canaan) is an American venture capital firm headquartered in Stamford, Connecticut with offices in San Francisco, Menlo Park and New York City. The firm focuses on investing in early stage companies in the technology and healthcare industries. Since 2014, the firm has also been investing in technology companies based in Israel.
Versant Ventures ("Versant") is an American Venture capital firm headquartered in San Francisco, California. It is focused on making investments in the healthcare and biotechnology industries.
